CXCL1 and liver cancer: This finding suggests that inhibiting CXCL1-CXCR2 signaling and NET formation may serve as an effective strategy to reduce liver cancer metastasis, particularly in patients with elevated acetyl-CoA levels, which opens new avenues for potential therapeutic targets (Pan et al., 2024).